Clinical trials as treatment option: Bioethics and health care disparities in substance dependency

Bioethicists have warned against the dangers of mixing research with treatment. They are concerned that research priorities may take precedence over individual patient needs and that research subjects tend to misunderstand the purpose of research or overestimate the direct medical benefits of partic...

Full description

Saved in:
Bibliographic Details
Published inSocial science & medicine (1982) Vol. 69; no. 12; pp. 1784 - 1790
Main Authors Timmermans, Stefan, McKay, Tara
Format Journal Article
LanguageEnglish
Published Kidlington Elsevier Ltd 01.12.2009
Elsevier
Pergamon Press Inc
SeriesSocial Science & Medicine
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Bioethicists have warned against the dangers of mixing research with treatment. They are concerned that research priorities may take precedence over individual patient needs and that research subjects tend to misunderstand the purpose of research or overestimate the direct medical benefits of participating in studies. Yet, other work has questioned whether clinical research can always be separated from therapeutic benefit for participants. Using in-depth interviews with participants in two phase III randomized U.S. clinical trials for methamphetamine dependency, we examine the treatment options available to participants, their experiences with participating in the trials, and potential problems of trial participation. We find that while participants have experience with four alternative treatment modalities – quitting alone, support groups, in-patient treatment facilities, and consulting primary care physicians – the randomized clinical trials compare favorably to alternatives because they provide access to evidence-based behavioral treatments, specialized medical professionals, non-judgmental staff, and the possibility of receiving an experimental drug. We conclude that while randomized clinical trials are imperfect substitutes for clinical care, they constitute a fragile and sporadic therapeutic niche in a country with fundamental problems in access to health care, a mixed punitive-therapeutic drug addiction policy, and a profit-driven pharmaceutical development and approval process.
AbstractList Bioethicists have warned against the dangers of mixing research with treatment. They are concerned that research priorities may take precedence over individual patient needs and that research subjects tend to misunderstand the purpose of research or overestimate the direct medical benefits of participating in studies. Yet, other work has questioned whether clinical research can always be separated from therapeutic benefit for participants. Using in-depth interviews with participants in two phase III randomized U.S. clinical trials for methamphetamine dependency, we examine the treatment options available to participants, their experiences with participating in the trials, and potential problems of trial participation. We find that while participants have experience with four alternative treatment modalities - quitting alone, support groups, in-patient treatment facilities, and consulting primary care physicians - the randomized clinical trials compare favorably to alternatives because they provide access to evidence-based behavioral treatments, specialized medical professionals, non-judgmental staff, and the possibility of receiving an experimental drug. We conclude that while randomized clinical trials are imperfect substitutes for clinical care, they constitute a fragile and sporadic therapeutic niche in a country with fundamental problems in access to health care, a mixed punitive-therapeutic drug addiction policy, and a profit-driven pharmaceutical development and approval process. [PUBLICATION ABSTRACT]
Bioethicists have warned against the dangers of mixing research with treatment. They are concerned that research priorities may take precedence over individual patient needs and that research subjects tend to misunderstand the purpose of research or overestimate the direct medical benefits of participating in studies. Yet, other work has questioned whether clinical research can always be separated from therapeutic benefit for participants. Using in-depth interviews with participants in two phase III randomized U.S. clinical trials for methamphetamine dependency, we examine the treatment options available to participants, their experiences with participating in the trials, and potential problems of trial participation. We find that while participants have experience with four alternative treatment modalities - quitting alone, support groups, in-patient treatment facilities, and consulting primary care physicians - the randomized clinical trials compare favorably to alternatives because they provide access to evidence-based behavioral treatments, specialized medical professionals, non-judgmental staff, and the possibility of receiving an experimental drug. We conclude that while randomized clinical trials are imperfect substitutes for clinical care, they constitute a fragile and sporadic therapeutic niche in a country with fundamental problems in access to health care, a mixed punitive-therapeutic drug addiction policy, and a profit-driven pharmaceutical development and approval process. [Copyright Elsevier Ltd.]
Bioethicists have warned against the dangers of mixing research with treatment. They are concerned that research priorities may take precedence over individual patient needs and that research subjects tend to misunderstand the purpose of research or overestimate the direct medical benefits of participating in studies. Yet, other work has questioned whether clinical research can always be separated from therapeutic benefit for participants. Using in-depth interviews with participants in two phase III randomized U.S. clinical trials for methamphetamine dependency, we examine the treatment options available to participants, their experiences with participating in the trials, and potential problems of trial participation. We find that while participants have experience with four alternative treatment modalities - quitting alone, support groups, in-patient treatment facilities, and consulting primary care physicians - the randomized clinical trials compare favorably to alternatives because they provide access to evidence-based behavioral treatments, specialized medical professionals, non-judgmental staff, and the possibility of receiving an experimental drug. We conclude that while randomized clinical trials are imperfect substitutes for clinical care, they constitute a fragile and sporadic therapeutic niche in a country with fundamental problems in access to health care, a mixed punitive-therapeutic drug addiction policy, and a profit-driven pharmaceutical development and approval process.Bioethicists have warned against the dangers of mixing research with treatment. They are concerned that research priorities may take precedence over individual patient needs and that research subjects tend to misunderstand the purpose of research or overestimate the direct medical benefits of participating in studies. Yet, other work has questioned whether clinical research can always be separated from therapeutic benefit for participants. Using in-depth interviews with participants in two phase III randomized U.S. clinical trials for methamphetamine dependency, we examine the treatment options available to participants, their experiences with participating in the trials, and potential problems of trial participation. We find that while participants have experience with four alternative treatment modalities - quitting alone, support groups, in-patient treatment facilities, and consulting primary care physicians - the randomized clinical trials compare favorably to alternatives because they provide access to evidence-based behavioral treatments, specialized medical professionals, non-judgmental staff, and the possibility of receiving an experimental drug. We conclude that while randomized clinical trials are imperfect substitutes for clinical care, they constitute a fragile and sporadic therapeutic niche in a country with fundamental problems in access to health care, a mixed punitive-therapeutic drug addiction policy, and a profit-driven pharmaceutical development and approval process.
Bioethicists have warned against the dangers of mixing research with treatment. They are concerned that research priorities may take precedence over individual patient needs and that research subjects tend to misunderstand the purpose of research or overestimate the direct medical benefits of participating in studies. Yet, other work has questioned whether clinical research can always be separated from therapeutic benefit for participants. Using in-depth interviews with participants in two phase III randomized U.S. clinical trials for methamphetamine dependency, we examine the treatment options available to participants, their experiences with participating in the trials, and potential problems of trial participation. We find that while participants have experience with four alternative treatment modalities - quitting alone, support groups, in-patient treatment facilities, and consulting primary care physicians - the randomized clinical trials compare favorably to alternatives because they provide access to evidence-based behavioral treatments, specialized medical professionals, non-judgmental staff, and the possibility of receiving an experimental drug. We conclude that while randomized clinical trials are imperfect substitutes for clinical care, they constitute a fragile and sporadic therapeutic niche in a country with fundamental problems in access to health care, a mixed punitive-therapeutic drug addiction policy, and a profit-driven pharmaceutical development and approval process.
Bioethicists have warned against the dangers of mixing research with treatment. They are concerned that research priorities may take precedence over individual patient needs and that research subjects tend to misunderstand the purpose of research or overestimate the direct medical benefits of participating in studies. Yet, other work has questioned whether clinical research can always be separated from therapeutic benefit for participants. Using in-depth interviews with participants in two phase III randomized U.S. clinical trials for methamphetamine dependency, we examine the treatment options available to participants, their experiences with participating in the trials, and potential problems of trial participation. We find that while participants have experience with four alternative treatment modalities - quitting alone, support groups, in-patient treatment facilities, and consulting primary care physicians - the randomized clinical trials compare favorably to alternatives because they provide access to evidence-based behavioral treatments, specialized medical professionals, non-judgmental staff, and the possibility of receiving an experimental drug. We conclude that while randomized clinical trials are imperfect substitutes for clinical care, they constitute a fragile and sporadic therapeutic niche in a country with fundamental problems in access to health care, a mixed punitive-therapeutic drug addiction policy, and a profit-driven pharmaceutical development and approval process. All rights reserved, Elsevier
Author Timmermans, Stefan
McKay, Tara
Author_xml – sequence: 1
  givenname: Stefan
  surname: Timmermans
  fullname: Timmermans, Stefan
  email: stefan@soc.ucla.edu
– sequence: 2
  givenname: Tara
  surname: McKay
  fullname: McKay, Tara
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22225524$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/19819059$$D View this record in MEDLINE/PubMed
http://econpapers.repec.org/article/eeesocmed/v_3a69_3ay_3a2009_3ai_3a12_3ap_3a1784-1790.htm$$DView record in RePEc
BookMark eNqNktuKFDEQhhtZcQ_6CtoI6tWMOXSSjuDFOniCFW_0OqSTaiZDT7pNMgvz9lY7syvshWNIKoF89VdI_ZfVWRwjVNULSpaUUPl2s8yjyy5swS8ZIXo5T6ofVRe0VXwheKPOqgvClFpoweV5dZnzhhBCScufVOdUt1QToS-qbjWEGJwd6pKCHXJtM57Ali3EUo9TCWN8V38II5R1cHgdfb0GO5R17WyC2oc82RRKgFyHWOddl4uNDi9ggughuv3T6nGPyvDsuF9VPz99_LH6srj5_vnr6vpm4YQmZcGIEs5b0bGGqdYr73smiOo7Kygwie-VDXSEecel7p1mpOk67ZinGDsp-VX15qA7pfHXDnIx25AdDIONMO6yUbyhkqEmkq__SUrKBW01Pw0SziWn6iTIFROM6RbBlw_AzbhLEf_FME6aVhOuEfp2gBJ-ojNTClub9gYAsOvYcnNruJUawx7X3H_cAi7KMEzzQbWNoUoTsy5b1Ht-LLrr5vQ7wTsbIPDqCNiMXugTtjDke47hEII1yKkD59KYc4L-rxQxszHNxtwb0_x52DzpXOH9g0wXip3dVZINw3_kXx_yAR10GyAZhNBd4EMCV4wfw0mN3ysGAqw
CODEN SSMDEP
CitedBy_id crossref_primary_10_3917_rac_017_0185
crossref_primary_10_1016_j_socscimed_2009_09_015
crossref_primary_10_9758_cpn_2016_14_1_17
crossref_primary_10_1093_phe_phw004
crossref_primary_10_1007_s12687_014_0186_0
crossref_primary_10_1111_maq_12647
crossref_primary_10_1177_10497323211016408
crossref_primary_10_1177_1740774515589592
crossref_primary_10_1016_j_socscimed_2009_09_014
crossref_primary_10_3917_sss_361_0005
crossref_primary_10_1080_17530350_2011_535332
crossref_primary_10_1016_j_socscimed_2016_08_019
crossref_primary_10_1097_QAI_0000000000001814
crossref_primary_10_3390_ijerph18052611
crossref_primary_10_3917_autr_063_0145
crossref_primary_10_1371_journal_pmed_1003705
crossref_primary_10_1016_j_socscimed_2022_115132
crossref_primary_10_1186_1475_2875_13_217
crossref_primary_10_1016_j_socscimed_2013_12_011
crossref_primary_10_3917_rfs_613_0405
crossref_primary_10_1051_medsci_2012281s109
crossref_primary_10_1186_1472_6939_15_68
crossref_primary_10_1097_PSY_0b013e318218e1fb
crossref_primary_10_1111_1467_9566_13297
crossref_primary_10_1177_0306312712472406
crossref_primary_10_1200_OP_21_00328
crossref_primary_10_1016_j_socscimed_2010_02_012
crossref_primary_10_4000_anthropologiesante_6272
crossref_primary_10_1111_j_1548_1387_2012_01222_x
crossref_primary_10_1016_j_socscimed_2011_11_012
crossref_primary_10_1590_1981_7746_sol00139
crossref_primary_10_1590_1983_80422020284430
crossref_primary_10_1177_0022146516684537
crossref_primary_10_1016_j_hlpt_2015_10_002
crossref_primary_10_1525_sod_2019_5_1_9
crossref_primary_10_1016_j_socscimed_2014_08_023
crossref_primary_10_1057_biosoc_2014_14
crossref_primary_10_1177_16094069221131168
crossref_primary_10_1016_j_drugalcdep_2011_11_005
crossref_primary_10_1016_j_socscimed_2012_04_022
crossref_primary_10_1177_0162243910366155
crossref_primary_10_1186_gm525
crossref_primary_10_1111_1467_9566_12094
crossref_primary_10_1111_1467_9566_13381
crossref_primary_10_1016_j_socscimed_2015_01_038
crossref_primary_10_1057_biosoc_2016_11
crossref_primary_10_1080_23294515_2017_1305007
Cites_doi 10.1353/pbm.2005.0092
10.1111/j.1748-720X.2000.tb00685.x
10.1097/01.CCM.0000054907.33928.48
10.1056/NEJMsb030228
10.1086/341855
10.1017/S1745855207005042
10.1016/0160-2527(82)90026-7
10.1111/j.1360-0443.2007.01773.x
10.1016/S0140-6736(01)06805-2
10.1371/journal.pmed.0040324
10.1353/hcr.2007.0092
10.1162/152651602317533523
10.1016/S0140-6736(03)15383-4
10.1017/S1745855207005029
10.1111/j.1360-0443.2008.02159.x
10.1177/0306312704043028
10.1016/j.socscimed.2007.12.006
10.1016/j.pharmthera.2005.06.014
10.1056/NEJMp0801872
10.1016/j.socscimed.2008.02.001
10.1111/j.1360-0443.2006.01774.x
10.1016/j.socscimed.2008.01.010
10.1111/j.1467-9566.2006.00537.x
10.1017/S1745855207005030
10.1111/j.1360-0443.2007.01779.x
10.1001/archpsyc.64.5.566
10.1001/jama.284.13.1689
10.1016/S0895-4356(00)00305-X
10.1007/s11920-007-0046-2
ContentType Journal Article
Copyright 2009 Elsevier Ltd
2015 INIST-CNRS
Copyright Pergamon Press Inc. Dec 2009
Copyright_xml – notice: 2009 Elsevier Ltd
– notice: 2015 INIST-CNRS
– notice: Copyright Pergamon Press Inc. Dec 2009
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
DKI
X2L
7U3
7U4
8BJ
BHHNA
DWI
FQK
JBE
K9.
WZK
7X8
DOI 10.1016/j.socscimed.2009.09.019
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
RePEc IDEAS
RePEc
Social Services Abstracts
Sociological Abstracts (pre-2017)
International Bibliography of the Social Sciences (IBSS)
Sociological Abstracts
Sociological Abstracts
International Bibliography of the Social Sciences
International Bibliography of the Social Sciences
ProQuest Health & Medical Complete (Alumni)
Sociological Abstracts (Ovid)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Sociological Abstracts (pre-2017)
ProQuest Health & Medical Complete (Alumni)
Social Services Abstracts
International Bibliography of the Social Sciences (IBSS)
Sociological Abstracts
MEDLINE - Academic
DatabaseTitleList Sociological Abstracts (pre-2017)
Sociological Abstracts (pre-2017)
Social Services Abstracts
MEDLINE - Academic


MEDLINE
International Bibliography of the Social Sciences (IBSS)
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: DKI
  name: RePEc IDEAS
  url: http://ideas.repec.org/
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Public Health
Social Sciences (General)
EISSN 1873-5347
EndPage 1790
ExternalDocumentID 1909118691
eeesocmed_v_3a69_3ay_3a2009_3ai_3a12_3ap_3a1784_1790_htm
19819059
22225524
10_1016_j_socscimed_2009_09_019
S0277953609006108
Genre Journal Article
Feature
GeographicLocations United States
North America
America
United States--US
GeographicLocations_xml – name: United States
– name: United States--US
GroupedDBID ---
--K
--M
-DZ
-~X
.GJ
.~1
07C
0R~
123
1B1
1RT
1~.
1~5
4.4
457
4G.
53G
5RE
5VS
6PF
7-5
71M
85S
8P~
9JM
9JO
AABNK
AACTN
AADFP
AAEDT
AAEDW
AAFJI
AAGJA
AAGJQ
AAGUQ
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQQT
AAWTL
AAXUO
ABBQC
ABFNM
ABIVO
ABJNI
ABLVK
ABMAC
ABMMH
ABMZM
ABOCM
ABOYX
ABPIV
ABPPZ
ABTAH
ABXDB
ABYKQ
ACDAQ
ACGFO
ACGFS
ACHQT
ACRLP
ACXNI
ADBBV
ADEZE
AEBSH
AEKER
AENEX
AFDAS
AFFNX
AFKWA
AFTJW
AFXIZ
AFYLN
AGHFR
AGUBO
AGYEJ
AHHHB
AHMBA
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJRQY
AKYCK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
AOMHK
ASPBG
AVARZ
AVWKF
AXJTR
AZFZN
BKOJK
BKOMP
BLXMC
BNPGV
CS3
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HEH
HMK
HMO
HMY
HVGLF
HZ~
IH2
IHE
J1W
K-O
KOM
L7B
LCYCR
M29
M3W
M3Y
M41
MO0
MVM
N9A
NHB
O-L
O9-
OAUVE
OHT
OKEIE
OZT
P-8
P-9
P2P
PC.
PQQKQ
PRBVW
Q38
R2-
RIG
ROL
RPZ
RXW
SAE
SCC
SDF
SDG
SDP
SES
SEW
SPCBC
SSB
SSH
SSO
SSS
SSY
SSZ
T5K
TAE
TN5
UHB
UQL
WH7
WUQ
X7L
XJT
XPP
YHZ
ZCA
ZGI
ZY4
~G-
AATTM
AAXKI
AAYWO
AAYXX
ACIEU
ACVFH
ADCNI
AEIPS
AEUPX
AFJKZ
AFPUW
AGCQF
AGRNS
AIGII
AIIUN
AKBMS
AKRWK
AKYEP
ANKPU
APXCP
CITATION
IQODW
CGR
CUY
CVF
ECM
EFKBS
EIF
NPM
-
08R
0R
1
1AW
8P
AAPBV
ABFLS
ABPTK
ACJLH
ADALY
AVTUQ
DKI
DZ
G-
GJ
HZ
IPNFZ
K
M
OHM
PQEST
STF
TAF
X
X2L
7U3
7U4
8BJ
BHHNA
DWI
FQK
JBE
K9.
WZK
7X8
ID FETCH-LOGICAL-c590t-2075cda5b24278d7ddf2507fba51e2619064eb02dc369fc9204bb9c2d1b9cb663
IEDL.DBID AIKHN
ISSN 0277-9536
1873-5347
IngestDate Fri Jul 11 14:17:34 EDT 2025
Fri Jul 11 09:47:27 EDT 2025
Fri Jul 11 00:50:26 EDT 2025
Fri Jul 11 09:45:42 EDT 2025
Wed Aug 13 10:39:38 EDT 2025
Wed Aug 18 03:10:19 EDT 2021
Mon Jul 21 05:36:42 EDT 2025
Wed Apr 02 07:25:59 EDT 2025
Tue Jul 01 01:59:38 EDT 2025
Thu Apr 24 23:12:38 EDT 2025
Fri Feb 23 02:17:12 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords Human subjects
USA
Substance dependency
Clinical trials
Bioethics
Research ethics
Pharmaceutical industry
Human
Social Inequality
Care
Ethics
Treatment
Scientific research
Dependence
Clinical trial
Social medicine
Public health
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c590t-2075cda5b24278d7ddf2507fba51e2619064eb02dc369fc9204bb9c2d1b9cb663
Notes SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-2
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
PMID 19819059
PQID 230489039
PQPubID 46002
PageCount 7
ParticipantIDs proquest_miscellaneous_734162250
proquest_miscellaneous_61351893
proquest_miscellaneous_60336317
proquest_miscellaneous_37252298
proquest_journals_230489039
repec_primary_eeesocmed_v_3a69_3ay_3a2009_3ai_3a12_3ap_3a1784_1790_htm
pubmed_primary_19819059
pascalfrancis_primary_22225524
crossref_primary_10_1016_j_socscimed_2009_09_019
crossref_citationtrail_10_1016_j_socscimed_2009_09_019
elsevier_sciencedirect_doi_10_1016_j_socscimed_2009_09_019
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2009-12-01
PublicationDateYYYYMMDD 2009-12-01
PublicationDate_xml – month: 12
  year: 2009
  text: 2009-12-01
  day: 01
PublicationDecade 2000
PublicationPlace Kidlington
PublicationPlace_xml – name: Kidlington
– name: England
– name: Oxford
PublicationSeriesTitle Social Science & Medicine
PublicationTitle Social science & medicine (1982)
PublicationTitleAlternate Soc Sci Med
PublicationYear 2009
Publisher Elsevier Ltd
Elsevier
Pergamon Press Inc
Publisher_xml – name: Elsevier Ltd
– name: Elsevier
– name: Pergamon Press Inc
References Appelbaum, Roth, Lidz (bib3) 1982; 5
Easter, Henderson, Davis, Churchill, King (bib14) 2006; 28
Worrall (bib51) 2002; 69
Donovan, Wells (bib13) 2007; 102
Braunholtz, Edwards, Lilford (bib7) 2001; 54
Henderson, Churchill, Davis, Easter, Grady, Joffe (bib25) 2007; 4
Himmelstein, Warren, Thorne, Woolhandler (bib26) 2005
Kimmelman (bib29) 2007; 37
Borders, Booth, Han, Wright, Leukefeld, Falck (bib6) 2008; 103
de Melo-Martin, Ho (bib33) 2008; 34
Katz (bib28) 1993; 38
Nicosia, Pacula, Kilmer, Lundberg, Chiesa (bib39) 2009
Miller, Rosentstein (bib35) 2003; 348
Ng (bib38) 2004
Compton, Thomas, Stinson, Grant (bib10) 2007; 64
McLellan, Lewis, O'Brien, Kleber (bib32) 2000; 284
Fatseas, Auriacombe (bib20) 2007; 9
Abraham (bib1) 2007; 2
Berg (bib5) 1997
Winslow, Voorhees, Pehl (bib50) 2007; 76
NDIC (bib37) 2008
Peppercorn, Weeks, Cook, Joffe (bib43) 2004; 363
Roll (bib45) 2007; 102
Pace, Miller, Danis (bib42) 2003; 31
Barr, Panenka, MacEwan, Thornton, Lang, Honer (bib4) 2006; 31
Epstein (bib17) 1996
Lakoff (bib31) 2005
Mumola, Karberg (bib36) 2007
Timmermans, Tavory (bib49) 2007
Miller, Brody (bib34) 2002; 2
Petryna (bib44) 2006; 2
SAMHSA (bib46) 2007
Owen (bib41) 2007
DeNavas-Walt, Proctor, Smith (bib12) 2007
Fisher, Goodman, Skinner, Wennberg (bib21) 2008
Elliott, Abadie (bib16) 2008; 358
Epstein (bib18) 2007
Chambliss (bib9) 1996
Anspach (bib2) 1993
Sismondo (bib48) 2008; 66
Joffe, Cook, Cleary, Clark, Weeks (bib27) 2001; 358
Cunningham, Liu (bib11) 2008; 66
Orr (bib40) 2006
Fisher (bib22) 2008; 66
Fishman (bib23) 2004; 34
Cartwright (bib8) 2007; 2
Grossman, MacKenzie (bib24) 2005; 48
Farmer (bib19) 2005
King (bib30) 2000; 28
Elkashef, Rawson, Smith, Pearce, Flammino, Campbell (bib15) 2007; 102
Saxon, McCarty (bib47) 2005; 108
Anspach (10.1016/j.socscimed.2009.09.019_bib2) 1993
DeNavas-Walt (10.1016/j.socscimed.2009.09.019_bib12) 2007
Orr (10.1016/j.socscimed.2009.09.019_bib40) 2006
Braunholtz (10.1016/j.socscimed.2009.09.019_bib7) 2001; 54
Miller (10.1016/j.socscimed.2009.09.019_bib35) 2003; 348
Appelbaum (10.1016/j.socscimed.2009.09.019_bib3) 1982; 5
Miller (10.1016/j.socscimed.2009.09.019_bib34) 2002; 2
Kimmelman (10.1016/j.socscimed.2009.09.019_bib29) 2007; 37
Easter (10.1016/j.socscimed.2009.09.019_bib14) 2006; 28
Elkashef (10.1016/j.socscimed.2009.09.019_bib15) 2007; 102
Mumola (10.1016/j.socscimed.2009.09.019_bib36) 2007
Farmer (10.1016/j.socscimed.2009.09.019_bib19) 2005
Grossman (10.1016/j.socscimed.2009.09.019_bib24) 2005; 48
Cunningham (10.1016/j.socscimed.2009.09.019_bib11) 2008; 66
Fishman (10.1016/j.socscimed.2009.09.019_bib23) 2004; 34
Cartwright (10.1016/j.socscimed.2009.09.019_bib8) 2007; 2
Joffe (10.1016/j.socscimed.2009.09.019_bib27) 2001; 358
Pace (10.1016/j.socscimed.2009.09.019_bib42) 2003; 31
Timmermans (10.1016/j.socscimed.2009.09.019_bib49) 2007
Elliott (10.1016/j.socscimed.2009.09.019_bib16) 2008; 358
Compton (10.1016/j.socscimed.2009.09.019_bib10) 2007; 64
Chambliss (10.1016/j.socscimed.2009.09.019_bib9) 1996
Peppercorn (10.1016/j.socscimed.2009.09.019_bib43) 2004; 363
de Melo-Martin (10.1016/j.socscimed.2009.09.019_bib33) 2008; 34
Abraham (10.1016/j.socscimed.2009.09.019_bib1) 2007; 2
Worrall (10.1016/j.socscimed.2009.09.019_bib51) 2002; 69
Berg (10.1016/j.socscimed.2009.09.019_bib5) 1997
Epstein (10.1016/j.socscimed.2009.09.019_bib17) 1996
Roll (10.1016/j.socscimed.2009.09.019_bib45) 2007; 102
Owen (10.1016/j.socscimed.2009.09.019_bib41) 2007
Katz (10.1016/j.socscimed.2009.09.019_bib28) 1993; 38
McLellan (10.1016/j.socscimed.2009.09.019_bib32) 2000; 284
Barr (10.1016/j.socscimed.2009.09.019_bib4) 2006; 31
Fisher (10.1016/j.socscimed.2009.09.019_bib21) 2008
Saxon (10.1016/j.socscimed.2009.09.019_bib47) 2005; 108
Henderson (10.1016/j.socscimed.2009.09.019_bib25) 2007; 4
Himmelstein (10.1016/j.socscimed.2009.09.019_bib26) 2005
Epstein (10.1016/j.socscimed.2009.09.019_bib18) 2007
SAMHSA (10.1016/j.socscimed.2009.09.019_bib46) 2007
Ng (10.1016/j.socscimed.2009.09.019_bib38) 2004
Fisher (10.1016/j.socscimed.2009.09.019_bib22) 2008; 66
Lakoff (10.1016/j.socscimed.2009.09.019_bib31) 2005
Borders (10.1016/j.socscimed.2009.09.019_bib6) 2008; 103
NDIC (10.1016/j.socscimed.2009.09.019_bib37) 2008
Winslow (10.1016/j.socscimed.2009.09.019_bib50) 2007; 76
Nicosia (10.1016/j.socscimed.2009.09.019_bib39) 2009
Fatseas (10.1016/j.socscimed.2009.09.019_bib20) 2007; 9
King (10.1016/j.socscimed.2009.09.019_bib30) 2000; 28
Petryna (10.1016/j.socscimed.2009.09.019_bib44) 2006; 2
Donovan (10.1016/j.socscimed.2009.09.019_bib13) 2007; 102
Sismondo (10.1016/j.socscimed.2009.09.019_bib48) 2008; 66
19819602 - Soc Sci Med. 2009 Dec;69(12):1791-2
References_xml – year: 1996
  ident: bib17
  article-title: Impure science: AIDS, activism, and the politics of knowledge
– year: 1996
  ident: bib9
  article-title: Beyond caring: Hospitals, nurses, and the social organization of ethics
– year: 2007
  ident: bib12
  article-title: Income, poverty, and health insurance coverage in the United States: 2006, Current population reports
– volume: 358
  start-page: 2316
  year: 2008
  end-page: 2317
  ident: bib16
  article-title: Exploiting a research underclass in phase 1 clinical trials
  publication-title: New England Journal of Medicine
– volume: 4
  start-page: 1735
  year: 2007
  end-page: 1738
  ident: bib25
  article-title: Clinical trials and medical care: defining the therapeutic misconception
  publication-title: PLOS Medicine
– volume: 66
  start-page: 1463
  year: 2008
  end-page: 1473
  ident: bib11
  article-title: Impact of methamphetamine precursor chemical legislation, a suppression policy, on the demand for drug treatment
  publication-title: Social Science & Medicine
– volume: 54
  start-page: 217
  year: 2001
  end-page: 224
  ident: bib7
  article-title: Are randomized clinical trials good for us (in the short term)? Evidence for a “trial effect”
  publication-title: Journal of Clinical Epidemiology
– year: 2005
  ident: bib19
  article-title: Pathologies of power: Health, human rights, and the new war on the poor
– volume: 358
  start-page: 1772
  year: 2001
  end-page: 1777
  ident: bib27
  article-title: Quality of informed consent in cancer clinical trials: a cross sectional survey
  publication-title: The Lancet
– volume: 64
  start-page: 566
  year: 2007
  end-page: 576
  ident: bib10
  article-title: Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States
  publication-title: Archives of General Psychiatry
– volume: 28
  start-page: 695
  year: 2006
  end-page: 712
  ident: bib14
  article-title: The many meanings of care in clinical research
  publication-title: Sociology of Health and Illness
– volume: 2
  start-page: 11
  year: 2007
  end-page: 20
  ident: bib8
  article-title: Are RCTs the gold standard?
  publication-title: BioSocieties
– volume: 34
  start-page: 187
  year: 2004
  end-page: 218
  ident: bib23
  article-title: Manufacturing desire: the commodification of female sexual dysfunction
  publication-title: Social Studies of Science
– volume: 38
  start-page: 7
  year: 1993
  end-page: 54
  ident: bib28
  article-title: Human experimentation and human rights
  publication-title: Saint Louis University Law Journal
– volume: 66
  start-page: 2495
  year: 2008
  end-page: 2505
  ident: bib22
  article-title: Practicing research ethics: private-sector physicians and pharmaceutical clinical trials
  publication-title: Social Science & Medicine
– year: 2008
  ident: bib21
  article-title: Tracking the care of patients with severe chronic illness: The Dartmouth atlas of health care 2008
– volume: 66
  start-page: 1909
  year: 2008
  end-page: 1914
  ident: bib48
  article-title: How pharmaceutical industry funding affects trial outcomes: causal structures and responses
  publication-title: Social Science & Medicine
– volume: 2
  start-page: 41
  year: 2007
  end-page: 56
  ident: bib1
  article-title: Drug trials and evidence bases in international regulatory context
  publication-title: BioSocieties
– volume: 31
  start-page: 301
  year: 2006
  end-page: 313
  ident: bib4
  article-title: The need for speed: an update on methamphetamine addiction
  publication-title: Journal of Psychiatry and Neuroscience
– volume: 103
  start-page: 800
  year: 2008
  end-page: 808
  ident: bib6
  article-title: Longitudinal changes in methamphetamine and cocaine use in untreated rural stimulant users: racial differences and the impact of methamphetamine legislation
  publication-title: Addiction
– year: 2004
  ident: bib38
  article-title: Drugs: From discovery to approval
– volume: 37
  start-page: 36
  year: 2007
  end-page: 42
  ident: bib29
  article-title: The therapeutic misconception at 25: treatment, research and confusion
  publication-title: Hastings Center Report
– year: 2005
  ident: bib31
  article-title: Pharmaceutical reason: Knowledge and value in global psychiatry
– volume: 9
  start-page: 358
  year: 2007
  end-page: 364
  ident: bib20
  article-title: Why buprenorphine is so successful in treating opiate addiction in France
  publication-title: Current Psychiatry Reports
– year: 2007
  ident: bib36
  article-title: Drug use and dependency, state and federal prisoners, 2004
– volume: 284
  start-page: 1689
  year: 2000
  end-page: 1695
  ident: bib32
  article-title: Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation
  publication-title: Journal of American Medical Association
– year: 2007
  ident: bib46
  article-title: Results from the 2006 national survey on drug use and health: National findings
– volume: 28
  start-page: 332
  year: 2000
  end-page: 343
  ident: bib30
  article-title: Defining and describing benefit appropriately in clinical trials
  publication-title: Journal of Law, Medicine, and Ethics
– volume: 102
  start-page: 114
  year: 2007
  end-page: 140
  ident: bib45
  article-title: Contingency management: an evidence-based component of methamphetamine use disorder treatments
  publication-title: Addiction
– year: 2009
  ident: bib39
  article-title: The economic cost of methamphetamine use in the United States, 2005
– year: 2007
  ident: bib41
  article-title: The speed limit: The highs and lows of meth
– volume: 108
  start-page: 119
  year: 2005
  end-page: 128
  ident: bib47
  article-title: Challenges in the adoption of new pharmacotherapeutics for addiction to alcohol and other drugs
  publication-title: Pharmacology and Therapeutics
– volume: 2
  start-page: 21
  year: 2006
  end-page: 40
  ident: bib44
  article-title: Clinical trials offshored: on private sector science and public health
  publication-title: BioSocieties
– volume: 5
  start-page: 319
  year: 1982
  end-page: 329
  ident: bib3
  article-title: The therapeutic misconception: informed consent in psychiatric research
  publication-title: International Journal of Law and Psychiatry
– volume: 2
  start-page: 3
  year: 2002
  end-page: 9
  ident: bib34
  article-title: What makes placebo-controlled trials unethical?
  publication-title: American Journal of Bioethics
– start-page: 493
  year: 2007
  end-page: 513
  ident: bib49
  article-title: Advancing ethnographic research through grounded theory practice
  publication-title: Handbook of grounded theory
– volume: 102
  start-page: 107
  year: 2007
  end-page: 113
  ident: bib15
  article-title: The NIDA methamphetamine clinical trials group: a strategy to increase clinical trials research capacity
  publication-title: Addiction
– volume: 348
  start-page: 1383
  year: 2003
  end-page: 1386
  ident: bib35
  article-title: The therapeutic orientation to clinical trials
  publication-title: New England Journal of Medicine
– year: 2007
  ident: bib18
  article-title: Inclusion: The politics of difference in medical research
– year: 2008
  ident: bib37
  article-title: National drug threat assessment
– year: 1997
  ident: bib5
  article-title: Rationalizing medical work: Decision support techniques and medical practices
– year: 1993
  ident: bib2
  article-title: Deciding who lives: Fateful choices in the intensive care nursery
– start-page: 65
  year: 2005
  end-page: 73
  ident: bib26
  article-title: Illness and injury as contributors to bankruptcy
  publication-title: Health Affairs(W5)
– volume: 102
  start-page: 121
  year: 2007
  end-page: 129
  ident: bib13
  article-title: ‘Tweaking 12-step’: the potential role of 12-step self-help group involvement in methamphetamine recovery
  publication-title: Addiction
– volume: 31
  start-page: S121
  year: 2003
  end-page: S125
  ident: bib42
  article-title: Enrolling the uninsured in clinical trials: an ethical perspective
  publication-title: Critical Care Medicine
– year: 2006
  ident: bib40
  article-title: Panic diaries: A genealogy of panic disorder
– volume: 76
  start-page: 1169
  year: 2007
  end-page: 1174
  ident: bib50
  article-title: Methamphetamine abuse
  publication-title: American Family Physician
– volume: 34
  start-page: 202
  year: 2008
  end-page: 205
  ident: bib33
  article-title: Beyond informed consent: the therapeutic misconception and trust
  publication-title: British Medical Journal
– volume: 363
  start-page: 263
  year: 2004
  end-page: 270
  ident: bib43
  article-title: Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review
  publication-title: Lancet
– volume: 69
  start-page: S316
  year: 2002
  end-page: S330
  ident: bib51
  article-title: What evidence in evidence-based medicine
  publication-title: Philosophy of Science
– volume: 48
  start-page: 516
  year: 2005
  end-page: 534
  ident: bib24
  article-title: The randomized controlled trial: gold standard or merely standard
  publication-title: Perspectives in Biology and Medicine
– volume: 48
  start-page: 516
  issue: 4
  year: 2005
  ident: 10.1016/j.socscimed.2009.09.019_bib24
  article-title: The randomized controlled trial: gold standard or merely standard
  publication-title: Perspectives in Biology and Medicine
  doi: 10.1353/pbm.2005.0092
– volume: 28
  start-page: 332
  year: 2000
  ident: 10.1016/j.socscimed.2009.09.019_bib30
  article-title: Defining and describing benefit appropriately in clinical trials
  publication-title: Journal of Law, Medicine, and Ethics
  doi: 10.1111/j.1748-720X.2000.tb00685.x
– volume: 31
  start-page: S121
  issue: 3
  year: 2003
  ident: 10.1016/j.socscimed.2009.09.019_bib42
  article-title: Enrolling the uninsured in clinical trials: an ethical perspective
  publication-title: Critical Care Medicine
  doi: 10.1097/01.CCM.0000054907.33928.48
– volume: 348
  start-page: 1383
  issue: 14
  year: 2003
  ident: 10.1016/j.socscimed.2009.09.019_bib35
  article-title: The therapeutic orientation to clinical trials
  publication-title: New England Journal of Medicine
  doi: 10.1056/NEJMsb030228
– year: 2005
  ident: 10.1016/j.socscimed.2009.09.019_bib31
– volume: 69
  start-page: S316
  year: 2002
  ident: 10.1016/j.socscimed.2009.09.019_bib51
  article-title: What evidence in evidence-based medicine
  publication-title: Philosophy of Science
  doi: 10.1086/341855
– volume: 2
  start-page: 41
  issue: 1
  year: 2007
  ident: 10.1016/j.socscimed.2009.09.019_bib1
  article-title: Drug trials and evidence bases in international regulatory context
  publication-title: BioSocieties
  doi: 10.1017/S1745855207005042
– volume: 38
  start-page: 7
  issue: 1
  year: 1993
  ident: 10.1016/j.socscimed.2009.09.019_bib28
  article-title: Human experimentation and human rights
  publication-title: Saint Louis University Law Journal
– volume: 5
  start-page: 319
  issue: 3–4
  year: 1982
  ident: 10.1016/j.socscimed.2009.09.019_bib3
  article-title: The therapeutic misconception: informed consent in psychiatric research
  publication-title: International Journal of Law and Psychiatry
  doi: 10.1016/0160-2527(82)90026-7
– volume: 102
  start-page: 121
  issue: Suppl. 1
  year: 2007
  ident: 10.1016/j.socscimed.2009.09.019_bib13
  article-title: ‘Tweaking 12-step’: the potential role of 12-step self-help group involvement in methamphetamine recovery
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2007.01773.x
– year: 1997
  ident: 10.1016/j.socscimed.2009.09.019_bib5
– year: 1996
  ident: 10.1016/j.socscimed.2009.09.019_bib17
– volume: 358
  start-page: 1772
  issue: 9295
  year: 2001
  ident: 10.1016/j.socscimed.2009.09.019_bib27
  article-title: Quality of informed consent in cancer clinical trials: a cross sectional survey
  publication-title: The Lancet
  doi: 10.1016/S0140-6736(01)06805-2
– year: 2004
  ident: 10.1016/j.socscimed.2009.09.019_bib38
– volume: 34
  start-page: 202
  issue: 3
  year: 2008
  ident: 10.1016/j.socscimed.2009.09.019_bib33
  article-title: Beyond informed consent: the therapeutic misconception and trust
  publication-title: British Medical Journal
– year: 2005
  ident: 10.1016/j.socscimed.2009.09.019_bib19
– volume: 4
  start-page: 1735
  issue: 11
  year: 2007
  ident: 10.1016/j.socscimed.2009.09.019_bib25
  article-title: Clinical trials and medical care: defining the therapeutic misconception
  publication-title: PLOS Medicine
  doi: 10.1371/journal.pmed.0040324
– volume: 37
  start-page: 36
  issue: 6
  year: 2007
  ident: 10.1016/j.socscimed.2009.09.019_bib29
  article-title: The therapeutic misconception at 25: treatment, research and confusion
  publication-title: Hastings Center Report
  doi: 10.1353/hcr.2007.0092
– volume: 2
  start-page: 3
  issue: 2
  year: 2002
  ident: 10.1016/j.socscimed.2009.09.019_bib34
  article-title: What makes placebo-controlled trials unethical?
  publication-title: American Journal of Bioethics
  doi: 10.1162/152651602317533523
– volume: 363
  start-page: 263
  issue: 9405
  year: 2004
  ident: 10.1016/j.socscimed.2009.09.019_bib43
  article-title: Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review
  publication-title: Lancet
  doi: 10.1016/S0140-6736(03)15383-4
– year: 2007
  ident: 10.1016/j.socscimed.2009.09.019_bib36
– year: 2007
  ident: 10.1016/j.socscimed.2009.09.019_bib41
– volume: 2
  start-page: 11
  issue: 1
  year: 2007
  ident: 10.1016/j.socscimed.2009.09.019_bib8
  article-title: Are RCTs the gold standard?
  publication-title: BioSocieties
  doi: 10.1017/S1745855207005029
– volume: 103
  start-page: 800
  year: 2008
  ident: 10.1016/j.socscimed.2009.09.019_bib6
  article-title: Longitudinal changes in methamphetamine and cocaine use in untreated rural stimulant users: racial differences and the impact of methamphetamine legislation
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2008.02159.x
– volume: 34
  start-page: 187
  issue: 2
  year: 2004
  ident: 10.1016/j.socscimed.2009.09.019_bib23
  article-title: Manufacturing desire: the commodification of female sexual dysfunction
  publication-title: Social Studies of Science
  doi: 10.1177/0306312704043028
– volume: 66
  start-page: 1463
  year: 2008
  ident: 10.1016/j.socscimed.2009.09.019_bib11
  article-title: Impact of methamphetamine precursor chemical legislation, a suppression policy, on the demand for drug treatment
  publication-title: Social Science & Medicine
  doi: 10.1016/j.socscimed.2007.12.006
– start-page: 65
  year: 2005
  ident: 10.1016/j.socscimed.2009.09.019_bib26
  article-title: Illness and injury as contributors to bankruptcy
  publication-title: Health Affairs(W5)
– volume: 108
  start-page: 119
  year: 2005
  ident: 10.1016/j.socscimed.2009.09.019_bib47
  article-title: Challenges in the adoption of new pharmacotherapeutics for addiction to alcohol and other drugs
  publication-title: Pharmacology and Therapeutics
  doi: 10.1016/j.pharmthera.2005.06.014
– volume: 358
  start-page: 2316
  issue: 22
  year: 2008
  ident: 10.1016/j.socscimed.2009.09.019_bib16
  article-title: Exploiting a research underclass in phase 1 clinical trials
  publication-title: New England Journal of Medicine
  doi: 10.1056/NEJMp0801872
– volume: 76
  start-page: 1169
  issue: 8
  year: 2007
  ident: 10.1016/j.socscimed.2009.09.019_bib50
  article-title: Methamphetamine abuse
  publication-title: American Family Physician
– year: 2007
  ident: 10.1016/j.socscimed.2009.09.019_bib46
– volume: 66
  start-page: 2495
  issue: 12
  year: 2008
  ident: 10.1016/j.socscimed.2009.09.019_bib22
  article-title: Practicing research ethics: private-sector physicians and pharmaceutical clinical trials
  publication-title: Social Science & Medicine
  doi: 10.1016/j.socscimed.2008.02.001
– volume: 102
  start-page: 114
  issue: Suppl. 1
  year: 2007
  ident: 10.1016/j.socscimed.2009.09.019_bib45
  article-title: Contingency management: an evidence-based component of methamphetamine use disorder treatments
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2006.01774.x
– volume: 66
  start-page: 1909
  year: 2008
  ident: 10.1016/j.socscimed.2009.09.019_bib48
  article-title: How pharmaceutical industry funding affects trial outcomes: causal structures and responses
  publication-title: Social Science & Medicine
  doi: 10.1016/j.socscimed.2008.01.010
– year: 2008
  ident: 10.1016/j.socscimed.2009.09.019_bib21
– volume: 28
  start-page: 695
  issue: 6
  year: 2006
  ident: 10.1016/j.socscimed.2009.09.019_bib14
  article-title: The many meanings of care in clinical research
  publication-title: Sociology of Health and Illness
  doi: 10.1111/j.1467-9566.2006.00537.x
– volume: 2
  start-page: 21
  issue: 1
  year: 2006
  ident: 10.1016/j.socscimed.2009.09.019_bib44
  article-title: Clinical trials offshored: on private sector science and public health
  publication-title: BioSocieties
  doi: 10.1017/S1745855207005030
– volume: 102
  start-page: 107
  issue: Suppl. 1
  year: 2007
  ident: 10.1016/j.socscimed.2009.09.019_bib15
  article-title: The NIDA methamphetamine clinical trials group: a strategy to increase clinical trials research capacity
  publication-title: Addiction
  doi: 10.1111/j.1360-0443.2007.01779.x
– volume: 64
  start-page: 566
  issue: May
  year: 2007
  ident: 10.1016/j.socscimed.2009.09.019_bib10
  article-title: Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States
  publication-title: Archives of General Psychiatry
  doi: 10.1001/archpsyc.64.5.566
– volume: 284
  start-page: 1689
  issue: 13
  year: 2000
  ident: 10.1016/j.socscimed.2009.09.019_bib32
  article-title: Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation
  publication-title: Journal of American Medical Association
  doi: 10.1001/jama.284.13.1689
– volume: 31
  start-page: 301
  issue: 5
  year: 2006
  ident: 10.1016/j.socscimed.2009.09.019_bib4
  article-title: The need for speed: an update on methamphetamine addiction
  publication-title: Journal of Psychiatry and Neuroscience
– year: 2007
  ident: 10.1016/j.socscimed.2009.09.019_bib18
– year: 1996
  ident: 10.1016/j.socscimed.2009.09.019_bib9
– year: 2006
  ident: 10.1016/j.socscimed.2009.09.019_bib40
– year: 1993
  ident: 10.1016/j.socscimed.2009.09.019_bib2
– volume: 54
  start-page: 217
  year: 2001
  ident: 10.1016/j.socscimed.2009.09.019_bib7
  article-title: Are randomized clinical trials good for us (in the short term)? Evidence for a “trial effect”
  publication-title: Journal of Clinical Epidemiology
  doi: 10.1016/S0895-4356(00)00305-X
– volume: 9
  start-page: 358
  issue: 5
  year: 2007
  ident: 10.1016/j.socscimed.2009.09.019_bib20
  article-title: Why buprenorphine is so successful in treating opiate addiction in France
  publication-title: Current Psychiatry Reports
  doi: 10.1007/s11920-007-0046-2
– year: 2007
  ident: 10.1016/j.socscimed.2009.09.019_bib12
– start-page: 493
  year: 2007
  ident: 10.1016/j.socscimed.2009.09.019_bib49
  article-title: Advancing ethnographic research through grounded theory practice
– year: 2008
  ident: 10.1016/j.socscimed.2009.09.019_bib37
– year: 2009
  ident: 10.1016/j.socscimed.2009.09.019_bib39
– reference: 19819602 - Soc Sci Med. 2009 Dec;69(12):1791-2
SSID ssj0001083
Score 2.2115617
Snippet Bioethicists have warned against the dangers of mixing research with treatment. They are concerned that research priorities may take precedence over individual...
SourceID proquest
repec
pubmed
pascalfrancis
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1784
SubjectTerms Addiction
Bioethical Issues
Bioethics
Biological and medical sciences
Clinical trials
Clinical Trials, Phase III as Topic - ethics
Conflict of Interest
Drug abuse
Drugs
Ethics
Health care
Health Services Accessibility - ethics
Healthcare Disparities
Human subjects
Humans
Interviews as Topic
Medical research
Medical sciences
Medications
Methamphetamine
Miscellaneous
Pharmaceutical industry
Primary care
Public health. Hygiene
Public health. Hygiene-occupational medicine
Randomized Controlled Trials as Topic - ethics
Research Design
Research Ethics
Research Subjects - psychology
Researcher-Subject Relations
Social research
Substance Abuse
Substance dependency
Substance-Related Disorders - therapy
Teaching. Deontology. Ethics. Legislation
U.S.A
United States
United States of America
USA
USA Clinical trials Pharmaceutical industry Human subjects Research ethics Substance dependency Bioethics
Title Clinical trials as treatment option: Bioethics and health care disparities in substance dependency
URI https://dx.doi.org/10.1016/j.socscimed.2009.09.019
https://www.ncbi.nlm.nih.gov/pubmed/19819059
http://econpapers.repec.org/article/eeesocmed/v_3a69_3ay_3a2009_3ai_3a12_3ap_3a1784-1790.htm
https://www.proquest.com/docview/230489039
https://www.proquest.com/docview/37252298
https://www.proquest.com/docview/60336317
https://www.proquest.com/docview/61351893
https://www.proquest.com/docview/734162250
Volume 69
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwELYoSFUlVMH2FWi3PvTQHtJNnMSJuQHtaimCS4vEzYofEaloNiIBiUt_e2cSJ4AE5YCUWLtrezc7Hs98ybwI-RTnBdcBZ77ghvmxypSfRVr5msUwBYsdFxiNfHTMFyfxj9PkdIXsD7Ew6FbpZH8v0ztp7T6ZOWrO6rKc_UTrIxofA4F6GAN-11gkOLD22u7B4eJ4FMjQ1xmab6yVt9y8gAbw7aB5XO5KODDrzv1Kar3OGyBd0de8uA-UAsa9sLXVt5TUfIO8dOiS7vZ_YJOs2GpCnh85-_mErPdP6WgffDQhXh-dS90Ob-hnl4b6yyuiXMrQc9pV9mho3tDRLZ0uO1GzQ_fKpe1c5mleGdpHVVJ0J6OmbLDCISZspWVFG5BQLbIYHeru6uvX5GT-_df-wncVGXydiKCFLZUm2uSJYlihw6TGFACh0kLlSWjxXgwAjlUBMzriotCCBbFSQjMTQqsA3Lwhq9Wysu8IzRQXiVCAQEwY6zhTCqCY6kKJM0wL5hE-LIHULl05Vs04l4Nf2m85rh0W0xQSj1B4JBgn1n3Gjsen7AxrLO8wnwS98vjk6R2uGH-U4a10wmKPbA9sIp2AaCQ-i89EEMH0j2Mv7Gw01-SVXV42MkoZgGORPTyCB1HEAQD-ZwQWYARI6hH6wIgUYAyHCwWCv-1Z-IZqAuFiApc473h67LDWAilw6JWMci6guYazI0qUl3CGDJoaX6RZLDELnDxr_2w9hc7b5AVztTuC8D1ZbS8u7QcAhK2akmdf_4ZTt-3h3bfDg3-EMGC7
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELaqIgFShWB5NBRaHzjAIWziOE7cG1SsFuj2Qiv1ZsWPiKCSjZptpV747cwkTraVWnpASqzV2t61xjPjL5kXIe94UQoTCRZKYVnIda7DPDE6NIzDFCx2XGI08uJIzE_4t9P0dIMcDLEw6FbpdX-v0ztt7b-ZempOm6qa_kDrIxofI4nnMAb8PuAgviidH_-s_TygpzMzr22V15y8gALw23Du-MyVcGHOnduPqK2maIFwZV_x4jZICgj33DXOXDuiZk_JE48t6ad--c_Ihqsn5OHCW88nZKt_R0f70KMJCfrYXOrlu6XvfRLqD8-J9glDz2hX16OlRUtHp3S67BTNPv1cLV3nME-L2tI-ppKiMxm1VYv1DTFdK61q2oJ-WiGD0aHqrrl6QU5mX44P5qGvxxCaVEYrEKgsNbZINcP6HDaztgQAlZW6SGOHT2IAb5yOmDWJkKWRLOJaS8NsDK0GaPOSbNbL2m0TmmshU6kBf9iYG55rDUBMd4HEOSYFC4gYtkAZn6wca2acqcEr7Zca9w5LaUqFVywDEo0Tmz5fx_1T9oc9VjdYT8Gpcv_k3RtcMf4pwwfplPGA7Axsorx6aBW-ic9llMD0vbEX5BqNNUXtlhetSjIG0Fjmd48QUZIIgH__GIHlFwGQBoTeMSIDECNgoUDwVz0Lr6kmESymsMRZx9Njh3MOSIFDL1VSCAnNFdwdUZKigjtm0DT4Icu5whxw6ufq9-v_ofMeeTQ_Xhyqw69H33fIY-areETxG7K5Or9wbwEarvRuJ_p_AS5zYIY
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+trials+as+treatment+option%3A+Bioethics+and+health+care+disparities+in+substance+dependency&rft.jtitle=Social+science+%26+medicine+%281982%29&rft.au=Timmermans%2C+Stefan&rft.au=McKay%2C+Tara&rft.series=Social+Science+%26+Medicine&rft.date=2009-12-01&rft.pub=Elsevier&rft.issn=0277-9536&rft.eissn=1873-5347&rft.volume=69&rft.issue=12&rft.spage=1784&rft.epage=1790&rft_id=info:doi/10.1016%2Fj.socscimed.2009.09.019&rft.externalDocID=eeesocmed_v_3a69_3ay_3a2009_3ai_3a12_3ap_3a1784_1790_htm
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0277-9536&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0277-9536&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0277-9536&client=summon